Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hehlmann

Leukemia

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Leukemia|May 24, 2003
Current CML therapy: progress and dilemmaR Hehlmann
Leukemia|September 20, 2000
Trial of IFN or STI571 before proceeding to allografting for CML?R Hehlmann
Leukemia|February 1, 1996
Chronic myelogenous leukemia: does interferon alpha prolong life?R Hehlmann
Leukemia|April 12, 2003
Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1)C A Schiffer, R Hehlmann, R Larson
Leukemia|December 1, 1988
Human endogenous retrovirusesR Hehlmann, R Brack-Werner, C Leib-Mösch
Leukemia|September 10, 2016
Prof. Thomas Büchner (22 September 1934-5 August 2016)-A leading European hematologist and AML trialistW E Berdel, R Hehlmann, D Hoelzer, et al.
Leukemia|March 13, 2001
Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemiaA Krämer, H Löffler, J Bergmann, et al.
Leukemia|December 15, 2012
Re-emergence of interferon-α in the treatment of chronic myeloid leukemiaM Talpaz, R Hehlmann, A Quintás-Cardama, et al.
Leukemia|October 3, 2003
Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndromeM Hummel, D Buchheidt, S Reiter, et al.
Leukemia|May 21, 2011
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemiaM Pfirrmann, A Hochhaus, M Lauseker, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Leukemia|May 24, 2003
Current CML therapy: progress and dilemmaR Hehlmann
Leukemia|September 20, 2000
Trial of IFN or STI571 before proceeding to allografting for CML?R Hehlmann
Leukemia|February 1, 1996
Chronic myelogenous leukemia: does interferon alpha prolong life?R Hehlmann
Leukemia|April 12, 2003
Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1)C A Schiffer, R Hehlmann, R Larson
Leukemia|December 1, 1988
Human endogenous retrovirusesR Hehlmann, R Brack-Werner, C Leib-Mösch
Leukemia|September 10, 2016
Prof. Thomas Büchner (22 September 1934-5 August 2016)-A leading European hematologist and AML trialistW E Berdel, R Hehlmann, D Hoelzer, et al.
Leukemia|March 13, 2001
Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemiaA Krämer, H Löffler, J Bergmann, et al.
Leukemia|December 15, 2012
Re-emergence of interferon-α in the treatment of chronic myeloid leukemiaM Talpaz, R Hehlmann, A Quintás-Cardama, et al.
Leukemia|October 3, 2003
Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndromeM Hummel, D Buchheidt, S Reiter, et al.
Leukemia|May 21, 2011
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemiaM Pfirrmann, A Hochhaus, M Lauseker, et al.
Pageof 8